Shimadzu Partners With Axio BioPharma on AI-Powered Cell Culture Media Optimization

PUBT · 1d ago
Shimadzu Partners With Axio BioPharma on AI-Powered Cell Culture Media Optimization
  • Shimadzu has begun collaborating with Wisconsin-based Axio BioPharma to optimize cell culture media for biopharmaceutical development using artificial intelligence.
  • The collaboration combines CellTune Ver. 2 software and the Media Blending Kit with Axio’s antibody expression and evaluation technologies.
  • Axio will test proposed culture conditions at its laboratory, feeding results into subsequent designs to validate an iterative media optimization workflow.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shimadzu Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.